The effects of central cholecystokinin receptor blockade on hypothalamic-pituitary-adrenal and symptomatic responses to overnight withdrawal from alprazolam

Biol Psychiatry. 1995 Jan 1;37(1):56-9. doi: 10.1016/0006-3223(94)00193-7.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Alprazolam / adverse effects*
  • Cross-Over Studies
  • Double-Blind Method
  • Humans
  • Hypothalamo-Hypophyseal System / drug effects*
  • Indoles / pharmacology*
  • Meglumine / analogs & derivatives*
  • Meglumine / pharmacology
  • Middle Aged
  • Pituitary-Adrenal System / drug effects*
  • Receptors, Cholecystokinin / antagonists & inhibitors*
  • Substance Withdrawal Syndrome / metabolism*

Substances

  • Indoles
  • Receptors, Cholecystokinin
  • PD 134308
  • Meglumine
  • Alprazolam